Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma
Authors:
- Riccardo NevolaRNRiccardo Nevola
- Giovanni TortorellaGTGiovanni Tortorella
- Valerio RosatoVRValerio Rosato
- Luca RinaldiLRLuca Rinaldi
- Simona ImbrianiSISimona Imbriani
- Pasquale PerilloPPPasquale Perillo
- Davide MastrocinqueDMDavide Mastrocinque
- Marco La MontagnaMMMarco La Montagna
- Antonio RussoARAntonio Russo
- Giovanni Di LorenzoGLGiovanni Di Lorenzo
- Maria AlfanoMAMaria Alfano
- Maria RoccoMRMaria Rocco
Top Cited Papers
Open Access
Abstract
Several chronic liver diseases are characterized by a clear gender disparity. Among them, hepatocellular carcinoma (HCC) shows significantly higher incidence rates in men than in women. The different epidemiological distribution of risk factors for liver disease and HCC only partially accounts for these gender differences. In fact, the liver is an organ with recognized sexual dysmorphism and is extremely sensitive to the action of androgens and estrogens. Sex hormones act by modulating the risk of developing HCC and influencing its aggressiveness, response to treatments, and prognosis. Furthermore, androgens and estrogens are able to modulate the action of other factors and cofactors of liver damage (e.g., chronic HBV infection, obesity), significantly influencing their carcinogenic power. The purpose of this review is to examine the factors related to the different gender distribution in the incidence of HCC as well as the pathophysiological mechanisms involved, with particular reference to the central role played by sex hormones.Keywords
This publication has 179 references indexed in Scilit:
- Estrogen synthesis and signaling pathways during aging: from periphery to brainTrends in Molecular Medicine, 2013
- Androgen Receptor Influences on Body Defense System via Modulation of Innate and Adaptive Immune SystemsThe American Journal of Pathology, 2012
- Foxa1 and Foxa2 Are Essential for Sexual Dimorphism in Liver CancerCell, 2012
- Interferon-gamma induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1)Cancer Letters, 2012
- Cell cycle–related kinase is a direct androgen receptor–regulated gene that drives β-catenin/T cell factor–dependent hepatocarcinogenesisJournal of Clinical Investigation, 2011
- miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNAMolecular and Cellular Biology, 2009
- Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated SignalingJournal of Virology, 2008
- Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular CarcinomaGastroenterology, 2008
- Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver TumorigenesisCancer Cell, 2008
- Concomitant Activation of the JAK/STAT, PI3K/AKT, and ERK Signaling Is Involved in Leptin-Mediated Promotion of Invasion and Migration of Hepatocellular Carcinoma CellsCancer Research, 2007